Women are being prescribed GLP-1 weight-loss drugs at higher rates than men, new data shows. Why it matters: This is another cultural moment when women, especially those approaching menopause, are ...

The potential benefits of GLP-1 medications continue to expand. New research has found that the weight loss and diabetes drugs — officially known as glucagon-like peptide 1 receptor agonists — are ...

Despite weight loss drugs' popularity, the “average” woman is still in the plus category, and they are finding their options ...

GLP-1 receptor agonists—the popular class of weight-loss drugs that include semaglutide (Ozempic)—may carry underrecognized risks for women of reproductive age, according to new research from ...

The women's health company offers branded GLP-1 medications and a weight management platform. It first provides individuals with a GLP-1 blood test to screen for health markers and then it tailors one ...

Women with obesity who stopped taking GLP-1 receptor agonists (RAs) early in or before pregnancy gained seven more pounds than those who were never prescribed the weight-loss medications, according to ...

New national data reveal a sharp rise in GLP-1 prescriptions for young women, but low contraception use leaves many at risk of unintended pregnancy and uncertain outcomes for their babies. Study: ...

Biochemist Svetlana Mojsov, PhD, has been awarded the Frontiers of Knowledge Award in Biology and Biomedicine, presented by Spain’s BBVA Foundation, for her collaborative research with Daniel Drucker, ...

A new study hints that pregnant people who have previously taken drugs like Ozempic may face a higher risk of certain poor pregnancy outcomes. But more studies are needed to understand the finding.

Phoenix NP announced a continued rise in patient satisfaction across Arizona, noting that positive feedback has increased as more women seek safe, FDA-approved GLP-1 weight loss medications through ...

The discovery of GLP-1 and its role in regulating blood glucose was a major scientific breakthrough in diabetes research, yet turning this peptide hormone into an effective medication was no easy task ...